- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Dr Reddy’s Laboratories Ltd (REDY)
Assess today's live Dr Reddy’s Laboratories Ltd (REDY) share price, performance and insights using our live NSE: REDY stock exchange data.
Analyse the historical data and Dr Reddy’s Laboratories Ltd share price performance charts on this page. Our technical summary section provides analysis on Dr Reddy’s Laboratories share price buy/sell indicators using real-time data (or discuss the Dr Reddy’s Laboratories (REDY) stock price today with other investors in the Dr Reddy’s Laboratories NSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NSE REDY share price (ISIN: INE089A01031) to enhance your trading decisions with our free investment tools and resources.
What Is the Dr Reddy’s Laboratories Ltd Share Price Today?
The Dr Reddy’s Laboratories share price today is 1,234.50.
What Is the Stock Symbol for Dr Reddy’s Laboratories Ltd
The stock symbol (or 'ticker') for Dr Reddy’s Laboratories Ltd is "REDY."
What Stock Exchange Does Dr Reddy’s Laboratories Ltd Trade On?
Dr Reddy’s Laboratories Ltd is listed and trades on the NSE stock exchange.
Is Dr Reddy’s Laboratories Ltd a Good Stock to Buy?
Determining whether Dr Reddy’s Laboratories Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Dr Reddy’s Laboratories Ltd share price performance charts on this page. Our technical summary section provides analysis on Dr Reddy’s Laboratories share price buy/sell indicators using real-time data (or discuss the Dr Reddy’s Laboratories (REDY) stock price today with other investors in the Dr Reddy’s Laboratories NSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current NSE REDY share price (ISIN: INE089A01031) to enhance your trading decisions with our free investment tools and resources.
What Is the Dr Reddy’s Laboratories Ltd Share Price Today?
The Dr Reddy’s Laboratories share price today is 1,234.50.
What Is the Stock Symbol for Dr Reddy’s Laboratories Ltd
The stock symbol (or 'ticker') for Dr Reddy’s Laboratories Ltd is "REDY."
What Stock Exchange Does Dr Reddy’s Laboratories Ltd Trade On?
Dr Reddy’s Laboratories Ltd is listed and trades on the NSE stock exchange.
Is Dr Reddy’s Laboratories Ltd a Good Stock to Buy?
Determining whether Dr Reddy’s Laboratories Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
1,241.50
-3.40(-0.27%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,225.00
1,248.90
52 wk Range
1,020.00
1,379.70
REDY is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,225.001,248.90
52 wk Range
1,020.001,379.70
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.64%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.64%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
REDY Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a low earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Dr Reddy’s Laboratories Company Profile
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. The Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. The Others segment engages in developing therapies in the fields of oncology and inflammation; and research and development of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India.
Compare REDY to Peers and Sector
Metrics to compare | REDY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipREDYPeersSector | |
|---|---|---|---|---|
P/E Ratio | 18.3x | 23.6x | −0.5x | |
PEG Ratio | 3.28 | 0.35 | 0.00 | |
Price/Book | 2.8x | 3.5x | 2.6x | |
Price / LTM Sales | 3.0x | 3.8x | 3.3x | |
Upside (Analyst Target) | 3.6% | 15.4% | 48.1% | |
Fair Value Upside | Unlock | 10.3% | 7.7% | Unlock |
Earnings
Latest Release
Jan 20, 2026
EPS / Forecast
14.52 / 14.04
Revenue / Forecast
87.27B / 84.06B
People Also Watch
FAQ
What Is the Dr Reddy’s Laboratories (REDY) Share Price Today?
The live Dr Reddy’s Laboratories share price today is 1,241.50
What Stock Exchange Does Dr Reddy’s Laboratories (REDY) Trade On?
Dr Reddy’s Laboratories is listed and trades on the India National Stock Exchange.
What Is the Ticker (Stock Symbol) for Dr Reddy’s Laboratories?
The stock symbol (also called a 'ticker') for Dr Reddy’s Laboratories is "REDY."
Does Dr Reddy’s Laboratories Pay Dividends? What’s The Current REDY Dividend Yield?
Yes, REDY Pays Dividends to its Shareholders. The current Dr Reddy’s Laboratories dividend yield is 0.64%.
What Is the Current Dr Reddy’s Laboratories Market Cap?
As of today, Dr Reddy’s Laboratories market capitalisation is 1.03T.
What Is Dr Reddy’s Laboratories's (REDY) Earnings Per Share (TTM)?
The Dr Reddy’s Laboratories EPS is currently 67.93 (Trailing Twelve Months).
When Is the Next Dr Reddy’s Laboratories Earnings Date?
Dr Reddy’s Laboratories's next earnings report will be released on 07 May 2026.
Is REDY a Buy or Sell From a Technical Analyst Perspective?
Based on today's Dr Reddy’s Laboratories moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Dr Reddy’s Laboratories Stock Split?
Dr Reddy’s Laboratories has split 4 times. (See the REDY stock split history page for full effective split date and price information.)
How Many Employees Does Dr Reddy’s Laboratories Have?
Dr Reddy’s Laboratories has 27811 employees.
What is the current trading status of Dr Reddy’s Laboratories (REDY)?
As of 06 Feb 2026, Dr Reddy’s Laboratories (REDY) is trading at a price of 1,241.50, with a previous close of 1,244.90. The stock has fluctuated within a day range of 1,225.00 to 1,248.90, while its 52-week range spans from 1,020.00 to 1,379.70.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.